First published 9/28/2026, 9:52:15 AM · Last updated 9/28/2026, 9:52:15 AM

Radiological stability with clinical deterioration during tislelizumab-based therapy in a 64-year-old man with advanced esophageal squamous cell carcinoma: a case report

A journal case report documents a 64-year-old man with advanced esophageal squamous cell carcinoma who had radiological stability yet experienced clinical deterioration while receiving tislelizumab-based therapy. The supplied source metadata included only the publisher and content type and provided no additional clinical or outcome details.

Categories: public-health, science-and-space

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 6/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 1/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 2/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 2/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 2/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 1/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

The report records a discordance between radiological findings and clinical course during immunotherapy that may be of interest to clinicians and researchers.

Sources

Radiological stability with clinical deterioration during tislelizumab-based therapy in a 64-year-old man with advanced esophageal squamous cell carcinoma: a case report

Report an issue